易方达全球医药行业混合发起式(QDII)C(人民币)(019035)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
948.87 |
32,442,278.49 |
- |
424.26 |
| 存出保证金 |
120,574.97 |
196,716.68 |
4,021.32 |
13,723.78 |
| 交易性金融资产 |
1,501,702,621.88 |
1,203,271,230.26 |
879,731,665.55 |
889,764,285.38 |
| 其中:股票投资 |
1,501,702,621.88 |
1,203,271,230.26 |
879,731,665.55 |
857,867,139.56 |
| 债券投资 |
- |
- |
- |
31,897,145.82 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
2,907,918.50 |
- |
7,687,764.17 |
3,048,192.89 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
183,481.34 |
2,530,473.12 |
- |
953,487.30 |
| 应收申购款 |
23,560,241.09 |
21,420,816.32 |
2,646,254.60 |
6,118,461.28 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,665,394,778.56 |
1,347,038,990.84 |
946,205,324.96 |
1,024,133,227.64 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
253.72 |
22,578,125.85 |
3,727,680.11 |
- |
| 应付赎回款 |
40,317,633.26 |
35,881,905.12 |
2,462,652.67 |
3,729,947.53 |
| 应付管理人报酬 |
1,748,702.25 |
1,208,371.39 |
998,105.38 |
1,028,465.56 |
| 应付托管费 |
291,450.37 |
201,395.22 |
166,350.88 |
171,410.89 |
| 应付销售服务费 |
263,397.55 |
64,244.57 |
47,932.42 |
43,407.94 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
37.30 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
428,295.17 |
490,342.14 |
402,398.88 |
224,037.18 |
| 负债合计 |
43,049,732.32 |
60,424,384.29 |
7,805,120.34 |
5,197,306.40 |
| 所有者权益 |
| 实收基金 |
1,319,456,153.80 |
1,165,809,998.85 |
1,304,455,293.39 |
1,445,169,313.05 |
| 未分配利润 |
302,888,892.44 |
120,804,607.70 |
-366,055,088.77 |
-426,233,391.81 |
| 所有者权益合计 |
1,622,345,046.24 |
1,286,614,606.55 |
938,400,204.62 |
1,018,935,921.24 |
| 负债及所有者权益总计 |
1,665,394,778.56 |
1,347,038,990.84 |
946,205,324.96 |
1,024,133,227.64 |